Back to News
Market Impact: 0.2
CelluPro Receives EXCiPACT™ Certification for GMP-grade Cell Culture Media Manufacturing, Strengthening Global Biomanufacturing Supply Capabilities
Source: PR Newswire
Healthcare & BiotechCompany FundamentalsRegulation & Legislation
CelluPro achieved EXCiPACT GMP Certification for Pharmaceutical Auxiliary Materials, becoming the first Chinese cell-culture-media company referenced in the announcement to receive the credential. The certification strengthens the company's quality and regulatory positioning in serum-free cell culture media and bioprocess solutions, though the article provides no revenue, customer, or financial impact figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
More News
- OpenAI Trims Target Value & Volvo Cars Cuts 2,500 Jobs
- PG&E’s CEO says AI is ‘the best thing that could’ve ever happened to the grid’
- Defense giant Saab sees orders triple after Gripen fighter jet deal with Ukraine
- Volvo Cars shares plunge 25% amid China sales slump and fresh job cuts
- Mark Zuckerberg owns 13% of Meta but controls 61% of its votes. California’s wealth tax would bill him on the 13%
- Eni Raises Investor Payouts as High Fuel Prices Boost Cash Flow
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Track Guidance Changes Across a Coverage List With AI
- Stop Treating AI Like a Chatbot: What Are Agents, SubAgents, MCP, and Skills, and How Do They Actually Work?